Navigation Links
Progress on HIV/AIDS significant but insufficient

United Nations Secretary-General Kofi Annan shared his hope with a gathering of senior world officials at Headquarters that the 2001 Declaration of Commitment on HIV/AIDS would have heralded a response that matched the epidemic's scale, yet progress had been "significant but insufficient".

Citing achievements in the core areas of political leadership, funding, the intensity and reach of prevention programmes, and the availability of drug therapies, he said, however, that last year saw more new infections and more AIDS-related deaths than ever before. With the epidemic expanding at an accelerating rate and on every continent, treatment and prevention efforts were "nowhere near enough". For example, only 12 per cent of the people in need of antiretroviral therapies in low- and middle-income countries were receiving them.

He called for increased resources, better planning, better and more vocal leadership, and real investment in the empowerment of women and girls. Women now accounted for about half of all people living with HIV worldwide, but they were also the most courageous and creative champions in that fight. How the international community fared in the fight was crucial; only by meeting the challenge could it succeed in its efforts to build a humane, healthy and equitable world.

General Assembly President Jean Ping (Gabon) said that the HIV/AIDS threat in 2005 was much greater than when the Assembly met here four years ago. In every way, that threat had attained alarming proportions. In fact, he said, in 2004, the number of infected people had grown to about 5 million, and the number who had died had also grown, to 3.1 million in 2004, much more than for the four preceding years. The pandemic had also grown disturbingly worldwide, affecting new countries and new populations within countries, particularly women and girls, and 95 per cent of those infected were in low- and medium-income countries.

Given the quantum worsening in the ep
'"/>

Source:United Nations


Page: 1 2 3 4

Related biology news :

1. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
2. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
3. Progress being made in exploring potential use of stem cells to treat heart disease
4. Progress made in HIV vaccine development
5. Progress toward artificial photosynthesis?
6. New therapy for HIV/AIDS eliminates needles and excessive toxicity
7. South Africa still debating how to tackle HIV/AIDS when 5 million are infected
8. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
9. HIV/AIDS rates in Tijuana, Mexico increasing at alarming rate
10. International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy
11. Study defines effective microbicide design for HIV/AIDS prevention

Post Your Comments:
(Date:11/25/2009)...ssistant professors recently received funding from... research beneficial to understanding the environm...her Blackwood, assistant professor in the Departme...upport two separate research projects. , His fir...ommunities and Functions from the Leaf to the Land...
(Date:11/24/2009)...as been prescribed by traditional healers in Brazi...stomach pain to fever and flu. , Now for the firs...een able to scientifically prove the pain relievin...as Brazilian mint. , Testing this ancient South A...raciela Rocha was able to show that when prepared ...
(Date:11/24/2009)...ew doors to understanding how sounds associated wi... mammal or if they hear it at all. , The same t...NASA uses to detect flaws in the space shuttle,s b...sts to peek inside the giant head of a whale. The ...licas of a whale,s hearing anatomy using a breakth...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 1Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 2Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 3Encorium Group Completes Sale of its U S Business to Pierrel Research USA 3B Announces Management Changes 13076 4Male Sex Chromosome on Its Way Out 3A Study 51994 1Male Sex Chromosome on Its Way Out 3A Study 51994 2Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 1Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 2Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 3
...s in the small Georgian town of Reepham in Norfolk...ial, led by the University of East Anglia (UEA). ...d, the properties depend on heating oil for warmth... prove that environmentally-friendly renewable hea... being used is sustainable biodiesel manufactured ...
...) Based on a striking similarity between heart di... at Columbia University Medical Center have discov...art failure may also help treat the fatal muscular...he muscle-wasting Duchenne disease couldn,t appear...fore the age of 6, destroying their muscle cells. ...
...bacterium behind one of mankind,s deadliest scourg...mmerce Department,s National Institute of Standard...gy,s Brookhaven National Laboratory (BNL) move clo...controls the switching on and off of genes that ca...of Biological Chemistry paper* posted online this...
Other Biology News:Trailblazing rural community shows green heating oil a viable option 2While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy 2Long-sought protein structure may help reveal how 'gene switch' works 2Long-sought protein structure may help reveal how 'gene switch' works 3
(Date:11/25/2009)..., BEIJING,Nov.25/PRNewswire-Asia/--SinovacBiotech...announcedtodaythatitexecuted,ajointventure(JV)agre...o.,Ltd.(SinovacDalian).TheJVwillresearch,develop,p...llcontributeitsexpertise,andexperienceindeveloping...tywillbringitslanduserights,manufacturingfacilitie...
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaBio...yD.Quart,Pharm.D.,presidentandchiefexecutiveoffice...Conference. , ,Presentationdetailsareasfollows:,...esday,December1,2009,Time:2:00p.m.EasternTime,Loca...ef=,http://www.corporate-ir.net/ireye/,target=,_b...
(Date:11/24/2009)..., HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Nasda...ommunicationssystemsandservicesforthecommercial,in...scommercialbusinessgrouphasbeenawardedacontractfro...theLevel4bio-safetylab(BSL-4)replacementfacilityat...eases(USAMRIID)atFortDetrickinFrederick,Md. ,, ...
(Date:11/24/2009)... The New York investment bank ...SX:NEU) has agreed an AU$6.7 mil convertible note ...or. The private placement was arranged by KTA Capi...sor. , New York (PRWEB) N...tment bank KTA Capital, LLC ("KTA Capital&quo...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
.... 13 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a...ent and commercialization of small molecule therap...d that Paul L. Berns, President and,CEO, will pres...fe Sciences,Conference in New York. The Company,s...n) on,Tuesday, September 25, 2007. There will be a...
.... 13 Abaxis, Inc.,(Nasdaq: ABAX ), a medical pro...alysis systems, announced today that Clint Severso... Company, LLC Sixth Annual San,Francisco Instituti...r 24,2007 at 11:35 a.m. Pacific Time at The Ritz-C...is develops, manufactures and markets portable blo...
...o antisense drugs in development targeting glucago...eptor, - Includes research collaboration to ident...nal targets to treat metabolic diseases - Confer.... EDT at http://www.isisph...ceuticals, Inc. (Nasdaq: ISIS ) today announced a...
Other Biology Technology:Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference 2Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 2Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 3Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 4Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 5
... FAM-Labeled Substrate (green fluorescence; Ex=488...rotease activation • No lysing, fixing, or pe...e cell-permeable, fluorescently labeled inhibitors...sin-like activity in whole living cells. Select fr...
..., known as ChemiArrayTM Mouse Cytokine Antibody Ar...t methodologies. Besides the ability to detect pro...accurate reflection of active cytokine levels beca...plification step is needed. Furthermore, it is sim...
DNA Engine Thermal Cycler Chassis w/384-well block & motorized lid from Bio-Rad
...ay (MSTA) slides were designed to study protein ex...rom multiple species. Tissue slices from three di...ch can then be treated as a single histological sl... situ hybridization. This format allows a rapid ...
Biology Products: